MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Milestone Scientific EPS Ratio 2011-2026 | MLSS
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Milestone Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | -0.06 | -0.1 | -0.12 | -0.1 | -0.12 | -0.16 | -0.21 | -0.16 | -0.22 | -0.26 | -0.08 | 0.09 | -0.05 | -0.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.09 | -0.26 | -0.115 |
Quarterly EPS Ratio Milestone Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.01 | -0.02 | -0.02 | - | -0.02 | - | -0.02 | - | -0.02 | -0.03 | -0.02 | - | -0.03 | -0.04 | -0.03 | - | -0.03 | -0.04 | -0.01 | - | -0.02 | -0.06 | -0.03 | - | -0.06 | -0.02 | -0.02 | - | -0.12 | -0.04 | -0.06 | - | -0.04 | -0.05 | -0.02 | - | -0.06 | -0.06 | -0.03 | - | 0.07 | -0.09 | -0.02 | - | -0.02 | -0.01 | 0.01 | - | 0.01 | - | 0.01 | - | - | -0.01 | -0.02 | - | -0.04 | -0.02 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.07 | -0.12 | -0.0283 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical instruments industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
-1.87 | $ 16.47 | -1.08 % | $ 8.45 B |  USA |
 |
Atrion Corporation
ATRI
|
11 | - | - | $ 810 M | USA |
 |
Alcon
ALC
|
0.77 | $ 74.46 | -0.25 % | $ 40.4 B |  Schweiz |
 |
The Cooper Companies
COO
|
1.88 | $ 69.5 | -1.13 % | $ 13.8 B | USA |
 |
electroCore
ECOR
|
-1.65 | $ 7.04 | - | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
-4.91 | $ 9.6 | -1.54 % | $ 23.3 M | USA |
 |
BioLife Solutions
BLFS
|
-0.44 | $ 19.0 | -1.4 % | $ 875 M | USA |
 |
AtriCure
ATRC
|
-0.24 | $ 28.76 | -1.47 % | $ 1.37 B | USA |
 |
Glaukos Corporation
GKOS
|
-2.78 | $ 115.08 | -1.41 % | $ 5.57 B | USA |
 |
Haemonetics Corporation
HAE
|
3.33 | $ 58.1 | -0.54 % | $ 2.92 B | USA |
 |
Harvard Bioscience
HBIO
|
-1.28 | $ 5.53 | - | $ 245 M | USA |
 |
iRhythm Technologies
IRTC
|
-1.39 | $ 115.36 | -1.59 % | $ 3.69 B | USA |
 |
Repro Med Systems
KRMD
|
-0.06 | $ 4.25 | -0.23 % | $ 196 M | USA |
 |
Masimo Corporation
MASI
|
-5.72 | $ 178.34 | -0.08 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
-0.29 | $ 2.32 | -1.91 % | $ 106 M |  Israel |
 |
Envista Holdings Corporation
NVST
|
0.28 | $ 25.51 | -1.22 % | $ 4.29 B | USA |
 |
Pro-Dex
PDEX
|
2.73 | $ 48.53 | - | $ 160 M | USA |
 |
ICU Medical
ICUI
|
0.03 | $ 121.67 | -1.08 % | $ 3 B | USA |
 |
ResMed
RMD
|
5.34 | $ 224.04 | -0.34 % | $ 32.7 B | USA |
 |
InfuSystem Holdings
INFU
|
0.07 | $ 9.43 | - | $ 195 M | USA |
 |
Retractable Technologies
RVP
|
-0.43 | $ 0.71 | -0.07 % | $ 21.3 M | USA |
 |
Isoray
ISR
|
-1.4 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
8 | $ 449.17 | -0.75 % | $ 160 B | USA |
 |
STAAR Surgical Company
STAA
|
-1.62 | $ 21.44 | 2.29 % | $ 1.06 B | USA |
 |
Stereotaxis
STXS
|
-0.25 | $ 1.85 | -1.86 % | $ 168 M | USA |
 |
LeMaitre Vascular
LMAT
|
2.55 | $ 109.83 | 0.61 % | $ 2.49 B | USA |
 |
Teleflex Incorporated
TFX
|
-16.1 | $ 114.86 | -0.2 % | $ 5.13 B | USA |
 |
Merit Medical Systems
MMSI
|
2.17 | $ 66.72 | -1.61 % | $ 3.95 B | USA |
 |
Utah Medical Products
UTMD
|
3.48 | $ 63.75 | 1.3 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
-13.4 | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-1.08 | $ 21.68 | -5.49 % | $ 1.46 B | USA |
 |
West Pharmaceutical Services
WST
|
6.83 | $ 258.0 | 0.4 % | $ 18.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-3 | $ 11.45 | -1.63 % | $ 2.28 B | USA |
 |
NeuroMetrix
NURO
|
-3.96 | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
6.24 | $ 219.18 | -0.37 % | $ 21.6 B | USA |
 |
AngioDynamics
ANGO
|
-0.83 | $ 9.51 | -3.35 % | $ 389 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.83 | $ 154.32 | -0.59 % | $ 44.4 B | USA |
 |
Nephros
NEPH
|
-0.15 | $ 2.81 | -1.75 % | $ 29.2 M | USA |
 |
OraSure Technologies
OSUR
|
-0.94 | $ 3.05 | -1.14 % | $ 224 M | USA |
 |
Repligen Corporation
RGEN
|
0.64 | $ 116.46 | -0.42 % | $ 6.49 M | USA |